✦ LIBER ✦

Formation of Crossline as a Fluorescent Advanced Glycation End Productin Vitroandin Vivo

✍ Scribed by Hiroshi Obayashi; Koji Nakano; Hirofumi Shigeta; Makiko Yamaguchi; Kuniaki Yoshimori; Michiaki Fukui; Mitsuhiro Fujii; Yoshihiro Kitagawa; Naoto Nakamura; Ko Nakamura; Yoshitaka Nakazawa; Kazuharu Ienaga; Mitsuhiro Ohta; Masataka Nishimura; Iwao Fukui; Motoharu Kondo

Book ID: 115578978
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 119 KB
Volume: 226
Category: Article
ISSN: 0006-291X
DOI: 10.1006/bbrc.1996.1308

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Formation Mechanisms of Melanoidins and

Formation Mechanisms of Melanoidins and Fluorescent Pyridinium Compounds as Advanced Glycation End Products

✍ Fumitaka Hayase; Teruyuki Usui; Yoriyuki Ono; Yoshinobu Shirahashi; Tomomi Machi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

Immunochemical quantification of crossli

Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy

✍ Yamaguchi, M.; Nakamura, N.; Nakano, K.; Kitagawa, Y.; Shigeta, H.; Hasegawa, G. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

Crossline is a novel advanced glycation endproduct (AGE) which has both a crosslink and fluorescence similar to AGE-protein in vivo. To assess the association of AGEs to the development of diabetic retinopathy we developed a sensitive and specific enzyme-linked immunosorbent assay (ELISA) for crossl

Anti-Hypertensive Agents Inhibit In Vivo

Anti-Hypertensive Agents Inhibit In Vivo the Formation of Advanced Glycation End Products and Improve Renal Damage in a Type 2 Diabetic Nephropathy Rat Model

✍ Nangaku, M. 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 710 KB